Global Next Generation Cancer Diagnostics Market Size, Status and Forecast 2022
This report studies the global Next Generation Cancer Diagnostics market, analyzes and researches the Next Generation Cancer Diagnostics development status and forecast in United States, EU, Japan, China, India and Southeast Asia.
This report focuses on the top players in global market, like
This report focuses on the top players in global market, like
- Cepheid
- Koninklijke Philips N.V
- F. Hoffmann-La Roche Ltd
- Qiagen
- Novartis AG
- Abbott
- Thermo Fisher Scientific
- Opko Health
- Myriad Genetics
- Agilent Technologies
- GE Healthcare
- PerkinElmer
- Genomic Health
- Illumina
- Hologic
- Almac Group
- Janssen Global Services
- Sysmex Corporation
- United States
- EU
- Japan
- China
- India
- Southeast Asia
- Next Generation Sequencing
- qPCR & Multiplexing
- DNA Microarrays
- Other
- Hospitals
- Clinics
- Other
Global Next Generation Cancer Diagnostics Market Size, Status and Forecast 2022
1 INDUSTRY OVERVIEW OF NEXT GENERATION CANCER DIAGNOSTICS
1.1 Next Generation Cancer Diagnostics Market Overview
1.1.1 Next Generation Cancer Diagnostics Product Scope
1.1.2 Market Status and Outlook
1.2 Global Next Generation Cancer Diagnostics Market Size and Analysis by Regions
1.2.1 United States
1.2.2 EU
1.2.3 Japan
1.2.4 China
1.2.5 India
1.2.6 Southeast Asia
1.3 Next Generation Cancer Diagnostics Market by Type
1.3.1 Next Generation Sequencing
1.3.2 qPCR & Multiplexing
1.3.3 DNA Microarrays
1.3.4 Other
1.4 Next Generation Cancer Diagnostics Market by End Users/Application
1.4.1 Hospitals
1.4.2 Clinics
1.4.3 Other
2 GLOBAL NEXT GENERATION CANCER DIAGNOSTICS COMPETITION ANALYSIS BY PLAYERS
2.1 Next Generation Cancer Diagnostics Market Size (Value) by Players (2016 and 2017)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future
3 COMPANY (TOP PLAYERS) PROFILES
3.1 Cepheid
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Next Generation Cancer Diagnostics Revenue (Value) (2012-2017)
3.1.5 Recent Developments
3.2 Koninklijke Philips N.V
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Next Generation Cancer Diagnostics Revenue (Value) (2012-2017)
3.2.5 Recent Developments
3.3 F. Hoffmann-La Roche Ltd
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Next Generation Cancer Diagnostics Revenue (Value) (2012-2017)
3.3.5 Recent Developments
3.4 Qiagen
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Next Generation Cancer Diagnostics Revenue (Value) (2012-2017)
3.4.5 Recent Developments
3.5 Novartis AG
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Next Generation Cancer Diagnostics Revenue (Value) (2012-2017)
3.5.5 Recent Developments
3.6 Abbott
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Next Generation Cancer Diagnostics Revenue (Value) (2012-2017)
3.6.5 Recent Developments
3.7 Thermo Fisher Scientific
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Next Generation Cancer Diagnostics Revenue (Value) (2012-2017)
3.7.5 Recent Developments
3.8 Opko Health
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Next Generation Cancer Diagnostics Revenue (Value) (2012-2017)
3.8.5 Recent Developments
3.9 Myriad Genetics
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Next Generation Cancer Diagnostics Revenue (Value) (2012-2017)
3.9.5 Recent Developments
3.10 Agilent Technologies
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 Next Generation Cancer Diagnostics Revenue (Value) (2012-2017)
3.10.5 Recent Developments
3.11 GE Healthcare
3.12 PerkinElmer
3.13 Genomic Health
3.14 Illumina
3.15 Hologic
3.16 Almac Group
3.17 Janssen Global Services
3.18 Sysmex Corporation
4 GLOBAL NEXT GENERATION CANCER DIAGNOSTICS MARKET SIZE BY TYPE AND APPLICATION (2012-2017)
4.1 Global Next Generation Cancer Diagnostics Market Size by Type (2012-2017)
4.2 Global Next Generation Cancer Diagnostics Market Size by Application (2012-2017)
4.3 Potential Application of Next Generation Cancer Diagnostics in Future
4.4 Top Consumer/End Users of Next Generation Cancer Diagnostics
5 UNITED STATES NEXT GENERATION CANCER DIAGNOSTICS DEVELOPMENT STATUS AND OUTLOOK
5.1 United States Next Generation Cancer Diagnostics Market Size (2012-2017)
5.2 United States Next Generation Cancer Diagnostics Market Size and Market Share by Players (2016 and 2017)
6 EU NEXT GENERATION CANCER DIAGNOSTICS DEVELOPMENT STATUS AND OUTLOOK
6.1 EU Next Generation Cancer Diagnostics Market Size (2012-2017)
6.2 EU Next Generation Cancer Diagnostics Market Size and Market Share by Players (2016 and 2017)
7 JAPAN NEXT GENERATION CANCER DIAGNOSTICS DEVELOPMENT STATUS AND OUTLOOK
7.1 Japan Next Generation Cancer Diagnostics Market Size (2012-2017)
7.2 Japan Next Generation Cancer Diagnostics Market Size and Market Share by Players (2016 and 2017)
8 CHINA NEXT GENERATION CANCER DIAGNOSTICS DEVELOPMENT STATUS AND OUTLOOK
8.1 China Next Generation Cancer Diagnostics Market Size (2012-2017)
8.2 China Next Generation Cancer Diagnostics Market Size and Market Share by Players (2016 and 2017)
9 INDIA NEXT GENERATION CANCER DIAGNOSTICS DEVELOPMENT STATUS AND OUTLOOK
9.1 India Next Generation Cancer Diagnostics Market Size (2012-2017)
9.2 India Next Generation Cancer Diagnostics Market Size and Market Share by Players (2016 and 2017)
10 SOUTHEAST ASIA NEXT GENERATION CANCER DIAGNOSTICS DEVELOPMENT STATUS AND OUTLOOK
10.1 Southeast Asia Next Generation Cancer Diagnostics Market Size (2012-2017)
10.2 Southeast Asia Next Generation Cancer Diagnostics Market Size and Market Share by Players (2016 and 2017)
11 MARKET FORECAST BY REGIONS, TYPE AND APPLICATION (2017-2022)
11.1 Global Next Generation Cancer Diagnostics Market Size (Value) by Regions (2017-2022)
11.1.1 United States Next Generation Cancer Diagnostics Revenue and Growth Rate (2017-2022)
11.1.2 EU Next Generation Cancer Diagnostics Revenue and Growth Rate (2017-2022)
11.1.3 Japan Next Generation Cancer Diagnostics Revenue and Growth Rate (2017-2022)
11.1.4 China Next Generation Cancer Diagnostics Revenue and Growth Rate (2017-2022)
11.1.5 India Next Generation Cancer Diagnostics Revenue and Growth Rate (2017-2022)
11.1.6 Southeast Asia Next Generation Cancer Diagnostics Revenue and Growth Rate (2017-2022)
11.2 Global Next Generation Cancer Diagnostics Market Size (Value) by Type (2017-2022)
11.3 Global Next Generation Cancer Diagnostics Market Size by Application (2017-2022)
12 NEXT GENERATION CANCER DIAGNOSTICS MARKET DYNAMICS
12.1 Next Generation Cancer Diagnostics Market Opportunities
12.2 Next Generation Cancer Diagnostics Challenge and Risk
12.2.1 Competition from Opponents
12.2.2 Downside Risks of Economy
12.3 Next Generation Cancer Diagnostics Market Constraints and Threat
12.3.1 Threat from Substitute
12.3.2 Government Policy
12.3.3 Technology Risks
12.4 Next Generation Cancer Diagnostics Market Driving Force
12.4.1 Growing Demand from Emerging Markets
12.4.2 Potential Application
13 MARKET EFFECT FACTORS ANALYSIS
13.1 Technology Progress/Risk
13.1.1 Substitutes
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
13.3.1 Economic Fluctuations
13.3.2 Other Risk Factors
14 RESEARCH FINDING/CONCLUSION
15 APPENDIX
Methodology
Analyst Introduction
Data Source
The report requires updating with new data and is sent in 2-3 business days after order is placed.
1 INDUSTRY OVERVIEW OF NEXT GENERATION CANCER DIAGNOSTICS
1.1 Next Generation Cancer Diagnostics Market Overview
1.1.1 Next Generation Cancer Diagnostics Product Scope
1.1.2 Market Status and Outlook
1.2 Global Next Generation Cancer Diagnostics Market Size and Analysis by Regions
1.2.1 United States
1.2.2 EU
1.2.3 Japan
1.2.4 China
1.2.5 India
1.2.6 Southeast Asia
1.3 Next Generation Cancer Diagnostics Market by Type
1.3.1 Next Generation Sequencing
1.3.2 qPCR & Multiplexing
1.3.3 DNA Microarrays
1.3.4 Other
1.4 Next Generation Cancer Diagnostics Market by End Users/Application
1.4.1 Hospitals
1.4.2 Clinics
1.4.3 Other
2 GLOBAL NEXT GENERATION CANCER DIAGNOSTICS COMPETITION ANALYSIS BY PLAYERS
2.1 Next Generation Cancer Diagnostics Market Size (Value) by Players (2016 and 2017)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future
3 COMPANY (TOP PLAYERS) PROFILES
3.1 Cepheid
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Next Generation Cancer Diagnostics Revenue (Value) (2012-2017)
3.1.5 Recent Developments
3.2 Koninklijke Philips N.V
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Next Generation Cancer Diagnostics Revenue (Value) (2012-2017)
3.2.5 Recent Developments
3.3 F. Hoffmann-La Roche Ltd
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Next Generation Cancer Diagnostics Revenue (Value) (2012-2017)
3.3.5 Recent Developments
3.4 Qiagen
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Next Generation Cancer Diagnostics Revenue (Value) (2012-2017)
3.4.5 Recent Developments
3.5 Novartis AG
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Next Generation Cancer Diagnostics Revenue (Value) (2012-2017)
3.5.5 Recent Developments
3.6 Abbott
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Next Generation Cancer Diagnostics Revenue (Value) (2012-2017)
3.6.5 Recent Developments
3.7 Thermo Fisher Scientific
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Next Generation Cancer Diagnostics Revenue (Value) (2012-2017)
3.7.5 Recent Developments
3.8 Opko Health
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Next Generation Cancer Diagnostics Revenue (Value) (2012-2017)
3.8.5 Recent Developments
3.9 Myriad Genetics
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Next Generation Cancer Diagnostics Revenue (Value) (2012-2017)
3.9.5 Recent Developments
3.10 Agilent Technologies
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 Next Generation Cancer Diagnostics Revenue (Value) (2012-2017)
3.10.5 Recent Developments
3.11 GE Healthcare
3.12 PerkinElmer
3.13 Genomic Health
3.14 Illumina
3.15 Hologic
3.16 Almac Group
3.17 Janssen Global Services
3.18 Sysmex Corporation
4 GLOBAL NEXT GENERATION CANCER DIAGNOSTICS MARKET SIZE BY TYPE AND APPLICATION (2012-2017)
4.1 Global Next Generation Cancer Diagnostics Market Size by Type (2012-2017)
4.2 Global Next Generation Cancer Diagnostics Market Size by Application (2012-2017)
4.3 Potential Application of Next Generation Cancer Diagnostics in Future
4.4 Top Consumer/End Users of Next Generation Cancer Diagnostics
5 UNITED STATES NEXT GENERATION CANCER DIAGNOSTICS DEVELOPMENT STATUS AND OUTLOOK
5.1 United States Next Generation Cancer Diagnostics Market Size (2012-2017)
5.2 United States Next Generation Cancer Diagnostics Market Size and Market Share by Players (2016 and 2017)
6 EU NEXT GENERATION CANCER DIAGNOSTICS DEVELOPMENT STATUS AND OUTLOOK
6.1 EU Next Generation Cancer Diagnostics Market Size (2012-2017)
6.2 EU Next Generation Cancer Diagnostics Market Size and Market Share by Players (2016 and 2017)
7 JAPAN NEXT GENERATION CANCER DIAGNOSTICS DEVELOPMENT STATUS AND OUTLOOK
7.1 Japan Next Generation Cancer Diagnostics Market Size (2012-2017)
7.2 Japan Next Generation Cancer Diagnostics Market Size and Market Share by Players (2016 and 2017)
8 CHINA NEXT GENERATION CANCER DIAGNOSTICS DEVELOPMENT STATUS AND OUTLOOK
8.1 China Next Generation Cancer Diagnostics Market Size (2012-2017)
8.2 China Next Generation Cancer Diagnostics Market Size and Market Share by Players (2016 and 2017)
9 INDIA NEXT GENERATION CANCER DIAGNOSTICS DEVELOPMENT STATUS AND OUTLOOK
9.1 India Next Generation Cancer Diagnostics Market Size (2012-2017)
9.2 India Next Generation Cancer Diagnostics Market Size and Market Share by Players (2016 and 2017)
10 SOUTHEAST ASIA NEXT GENERATION CANCER DIAGNOSTICS DEVELOPMENT STATUS AND OUTLOOK
10.1 Southeast Asia Next Generation Cancer Diagnostics Market Size (2012-2017)
10.2 Southeast Asia Next Generation Cancer Diagnostics Market Size and Market Share by Players (2016 and 2017)
11 MARKET FORECAST BY REGIONS, TYPE AND APPLICATION (2017-2022)
11.1 Global Next Generation Cancer Diagnostics Market Size (Value) by Regions (2017-2022)
11.1.1 United States Next Generation Cancer Diagnostics Revenue and Growth Rate (2017-2022)
11.1.2 EU Next Generation Cancer Diagnostics Revenue and Growth Rate (2017-2022)
11.1.3 Japan Next Generation Cancer Diagnostics Revenue and Growth Rate (2017-2022)
11.1.4 China Next Generation Cancer Diagnostics Revenue and Growth Rate (2017-2022)
11.1.5 India Next Generation Cancer Diagnostics Revenue and Growth Rate (2017-2022)
11.1.6 Southeast Asia Next Generation Cancer Diagnostics Revenue and Growth Rate (2017-2022)
11.2 Global Next Generation Cancer Diagnostics Market Size (Value) by Type (2017-2022)
11.3 Global Next Generation Cancer Diagnostics Market Size by Application (2017-2022)
12 NEXT GENERATION CANCER DIAGNOSTICS MARKET DYNAMICS
12.1 Next Generation Cancer Diagnostics Market Opportunities
12.2 Next Generation Cancer Diagnostics Challenge and Risk
12.2.1 Competition from Opponents
12.2.2 Downside Risks of Economy
12.3 Next Generation Cancer Diagnostics Market Constraints and Threat
12.3.1 Threat from Substitute
12.3.2 Government Policy
12.3.3 Technology Risks
12.4 Next Generation Cancer Diagnostics Market Driving Force
12.4.1 Growing Demand from Emerging Markets
12.4.2 Potential Application
13 MARKET EFFECT FACTORS ANALYSIS
13.1 Technology Progress/Risk
13.1.1 Substitutes
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
13.3.1 Economic Fluctuations
13.3.2 Other Risk Factors
14 RESEARCH FINDING/CONCLUSION
15 APPENDIX
Methodology
Analyst Introduction
Data Source
The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES
Figure Next Generation Cancer Diagnostics Product Scope
Figure Global Next Generation Cancer Diagnostics Market Size (Million USD) (2012-2017)
Table Global Next Generation Cancer Diagnostics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Next Generation Cancer Diagnostics Market Share by Regions in 2016
Figure United States Next Generation Cancer Diagnostics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure EU Next Generation Cancer Diagnostics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Japan Next Generation Cancer Diagnostics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure China Next Generation Cancer Diagnostics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure India Next Generation Cancer Diagnostics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Southeast Asia Next Generation Cancer Diagnostics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Next Generation Cancer Diagnostics Market Share by Type in 2016
Figure Next Generation Sequencing Market Size (Million USD) and Growth Rate (2012-2017)
Figure qPCR & Multiplexing Market Size (Million USD) and Growth Rate (2012-2017)
Figure DNA Microarrays Market Size (Million USD) and Growth Rate (2012-2017)
Figure Other Market Size (Million USD) and Growth Rate (2012-2017)
Figure Global Next Generation Cancer Diagnostics Market Share by Application in 2016
Table Key Downstream Customer in Hospitals
Figure Next Generation Cancer Diagnostics Market Size (Million USD) and Growth Rate in Hospitals (2012-2017)
Table Key Downstream Customer in Clinics
Figure Next Generation Cancer Diagnostics Market Size (Million USD) and Growth Rate in Clinics (2012-2017)
Table Key Downstream Customer in Other
Figure Next Generation Cancer Diagnostics Market Size (Million USD) and Growth Rate in Other (2012-2017)
Table Next Generation Cancer Diagnostics Market Size (Million USD) by Players (2016 and 2017)
Figure Next Generation Cancer Diagnostics Market Size Share by Players in 2016
Figure Next Generation Cancer Diagnostics Market Size Share by Players in 2017
Table Cepheid Basic Information List
Table Next Generation Cancer Diagnostics Business Revenue (Million USD) of Cepheid (2012-2017)
Figure Cepheid Next Generation Cancer Diagnostics Business Revenue Market Share in 2016
Table Koninklijke Philips N.V Basic Information List
Table Next Generation Cancer Diagnostics Business Revenue (Million USD) of Koninklijke Philips N.V (2012-2017)
Figure Koninklijke Philips N.V Next Generation Cancer Diagnostics Business Revenue Market Share in 2016
Table F. Hoffmann-La Roche Ltd Basic Information List
Table Next Generation Cancer Diagnostics Business Revenue (Million USD) of F. Hoffmann-La Roche Ltd (2012-2017)
Figure F. Hoffmann-La Roche Ltd Next Generation Cancer Diagnostics Business Revenue Market Share in 2016
Table Qiagen Basic Information List
Table Next Generation Cancer Diagnostics Business Revenue (Million USD) of Qiagen (2012-2017)
Figure Qiagen Next Generation Cancer Diagnostics Business Revenue Market Share in 2016
Table Novartis AG Basic Information List
Table Next Generation Cancer Diagnostics Business Revenue (Million USD) of Novartis AG (2012-2017)
Figure Novartis AG Next Generation Cancer Diagnostics Business Revenue Market Share in 2016
Table Abbott Basic Information List
Table Next Generation Cancer Diagnostics Business Revenue (Million USD) of Abbott (2012-2017)
Figure Abbott Next Generation Cancer Diagnostics Business Revenue Market Share in 2016
Table Thermo Fisher Scientific Basic Information List
Table Next Generation Cancer Diagnostics Business Revenue (Million USD) of Thermo Fisher Scientific (2012-2017)
Figure Thermo Fisher Scientific Next Generation Cancer Diagnostics Business Revenue Market Share in 2016
Table Opko Health Basic Information List
Table Next Generation Cancer Diagnostics Business Revenue (Million USD) of Opko Health (2012-2017)
Figure Opko Health Next Generation Cancer Diagnostics Business Revenue Market Share in 2016
Table Myriad Genetics Basic Information List
Table Next Generation Cancer Diagnostics Business Revenue (Million USD) of Myriad Genetics (2012-2017)
Figure Myriad Genetics Next Generation Cancer Diagnostics Business Revenue Market Share in 2016
Table Agilent Technologies Basic Information List
Table Next Generation Cancer Diagnostics Business Revenue (Million USD) of Agilent Technologies (2012-2017)
Figure Agilent Technologies Next Generation Cancer Diagnostics Business Revenue Market Share in 2016
Table GE Healthcare Basic Information List
Table Next Generation Cancer Diagnostics Business Revenue (Million USD) of GE Healthcare (2012-2017)
Figure GE Healthcare Next Generation Cancer Diagnostics Business Revenue Market Share in 2016
Table PerkinElmer Basic Information List
Table Next Generation Cancer Diagnostics Business Revenue (Million USD) of PerkinElmer (2012-2017)
Figure PerkinElmer Next Generation Cancer Diagnostics Business Revenue Market Share in 2016
Table Genomic Health Basic Information List
Table Next Generation Cancer Diagnostics Business Revenue (Million USD) of Genomic Health (2012-2017)
Figure Genomic Health Next Generation Cancer Diagnostics Business Revenue Market Share in 2016
Table Illumina Basic Information List
Table Next Generation Cancer Diagnostics Business Revenue (Million USD) of Illumina (2012-2017)
Figure Illumina Next Generation Cancer Diagnostics Business Revenue Market Share in 2016
Table Hologic Basic Information List
Table Next Generation Cancer Diagnostics Business Revenue (Million USD) of Hologic (2012-2017)
Figure Hologic Next Generation Cancer Diagnostics Business Revenue Market Share in 2016
Table Almac Group Basic Information List
Table Next Generation Cancer Diagnostics Business Revenue (Million USD) of Almac Group (2012-2017)
Figure Almac Group Next Generation Cancer Diagnostics Business Revenue Market Share in 2016
Table Janssen Global Services Basic Information List
Table Next Generation Cancer Diagnostics Business Revenue (Million USD) of Janssen Global Services (2012-2017)
Figure Janssen Global Services Next Generation Cancer Diagnostics Business Revenue Market Share in 2016
Table Sysmex Corporation Basic Information List
Table Next Generation Cancer Diagnostics Business Revenue (Million USD) of Sysmex Corporation (2012-2017)
Figure Sysmex Corporation Next Generation Cancer Diagnostics Business Revenue Market Share in 2016
Table Global Next Generation Cancer Diagnostics Market Size (Million USD) by Type (2012-2017)
Figure Global Next Generation Cancer Diagnostics Market Size Share by Type in 2012
Figure Global Next Generation Cancer Diagnostics Market Size Share by Type in 2013
Figure Global Next Generation Cancer Diagnostics Market Size Share by Type in 2014
Figure Global Next Generation Cancer Diagnostics Market Size Share by Type in 2015
Figure Global Next Generation Cancer Diagnostics Market Size Share by Type in 2016
Figure Global Next Generation Cancer Diagnostics Market Size Share by Type in 2017
Table Global Next Generation Cancer Diagnostics Market Size (Million USD) by Application (2012-2017)
Figure Global Next Generation Cancer Diagnostics Market Size (Million USD) by Application in 2012
Figure Global Next Generation Cancer Diagnostics Market Size (Million USD) by Application in 2013
Figure Global Next Generation Cancer Diagnostics Market Size (Million USD) by Application in 2014
Figure Global Next Generation Cancer Diagnostics Market Size (Million USD) by Application in 2015
Figure Global Next Generation Cancer Diagnostics Market Size (Million USD) by Application in 2016
Figure Global Next Generation Cancer Diagnostics Market Size (Million USD) by Application in 2017
Table Top Consumer/End Users of Next Generation Cancer Diagnostics
Figure United States Next Generation Cancer Diagnostics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table United States Next Generation Cancer Diagnostics Market Size (Million USD) by Players (2012-2017)
Figure United States Next Generation Cancer Diagnostics Market Size Share by Players in 2016
Figure United States Next Generation Cancer Diagnostics Market Size Share by Players in 2017
Figure EU Next Generation Cancer Diagnostics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table EU Next Generation Cancer Diagnostics Market Size (Million USD) by Players (2012-2017)
Figure EU Next Generation Cancer Diagnostics Market Size Share by Players in 2016
Figure EU Next Generation Cancer Diagnostics Market Size Share by Players in 2017
Figure Japan Next Generation Cancer Diagnostics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Japan Next Generation Cancer Diagnostics Market Size (Million USD) by Players (2012-2017)
Figure Japan Next Generation Cancer Diagnostics Market Size Share by Players in 2016
Figure Japan Next Generation Cancer Diagnostics Market Size Share by Players in 2017
Figure China Next Generation Cancer Diagnostics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table China Next Generation Cancer Diagnostics Market Size (Million USD) by Players (2012-2017)
Figure China Next Generation Cancer Diagnostics Market Size Share by Players in 2016
Figure China Next Generation Cancer Diagnostics Market Size Share by Players in 2017
Figure India Next Generation Cancer Diagnostics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table India Next Generation Cancer Diagnostics Market Size (Million USD) by Players (2012-2017)
Figure India Next Generation Cancer Diagnostics Market Size Share by Players in 2016
Figure India Next Generation Cancer Diagnostics Market Size Share by Players in 2017
Figure Southeast Asia Next Generation Cancer Diagnostics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Southeast Asia Next Generation Cancer Diagnostics Market Size (Million USD) by Players (2012-2017)
Figure Southeast Asia Next Generation Cancer Diagnostics Market Size Share by Players in 2016
Figure Southeast Asia Next Generation Cancer Diagnostics Market Size Share by Players in 2017
Figure Global Next Generation Cancer Diagnostics Market Size (Million USD) by Regions (2017-2022)
Table Global Next Generation Cancer Diagnostics Market Size (Million USD) by Regions (2017-2022)
Figure Global Next Generation Cancer Diagnostics Market Size Share by Regions in 2017
Figure Global Next Generation Cancer Diagnostics Market Size Share by Regions in 2022
Figure United States Next Generation Cancer Diagnostics Revenue (Million USD) and Growth Rate (2017-2022)
Figure EU Next Generation Cancer Diagnostics Revenue (Million USD) and Growth Rate (2017-2022)
Figure Japan Next Generation Cancer Diagnostics Revenue (Million USD) and Growth Rate (2017-2022)
Figure China Next Generation Cancer Diagnostics Revenue (Million USD) and Growth Rate (2017-2022)
Figure India Next Generation Cancer Diagnostics Revenue (Million USD) and Growth Rate (2017-2022)
Figure Southeast Asia Next Generation Cancer Diagnostics Revenue (Million USD) and Growth Rate (2017-2022)
Table Global Next Generation Cancer Diagnostics Market Size (Million USD) by Type (2017-2022)
Figure Global Next Generation Cancer Diagnostics Market Size Share by Type in 2017
Figure Global Next Generation Cancer Diagnostics Market Size Share by Type in 2022
Table Global Next Generation Cancer Diagnostics Market Size (Million USD) by Application (2017-2022)
Figure Global Next Generation Cancer Diagnostics Market Size (Million USD) by Application in 2017
Figure Global Next Generation Cancer Diagnostics Market Size (Million USD) by Application in 2022
Figure Next Generation Cancer Diagnostics Product Scope
Figure Global Next Generation Cancer Diagnostics Market Size (Million USD) (2012-2017)
Table Global Next Generation Cancer Diagnostics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Next Generation Cancer Diagnostics Market Share by Regions in 2016
Figure United States Next Generation Cancer Diagnostics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure EU Next Generation Cancer Diagnostics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Japan Next Generation Cancer Diagnostics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure China Next Generation Cancer Diagnostics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure India Next Generation Cancer Diagnostics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Southeast Asia Next Generation Cancer Diagnostics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Next Generation Cancer Diagnostics Market Share by Type in 2016
Figure Next Generation Sequencing Market Size (Million USD) and Growth Rate (2012-2017)
Figure qPCR & Multiplexing Market Size (Million USD) and Growth Rate (2012-2017)
Figure DNA Microarrays Market Size (Million USD) and Growth Rate (2012-2017)
Figure Other Market Size (Million USD) and Growth Rate (2012-2017)
Figure Global Next Generation Cancer Diagnostics Market Share by Application in 2016
Table Key Downstream Customer in Hospitals
Figure Next Generation Cancer Diagnostics Market Size (Million USD) and Growth Rate in Hospitals (2012-2017)
Table Key Downstream Customer in Clinics
Figure Next Generation Cancer Diagnostics Market Size (Million USD) and Growth Rate in Clinics (2012-2017)
Table Key Downstream Customer in Other
Figure Next Generation Cancer Diagnostics Market Size (Million USD) and Growth Rate in Other (2012-2017)
Table Next Generation Cancer Diagnostics Market Size (Million USD) by Players (2016 and 2017)
Figure Next Generation Cancer Diagnostics Market Size Share by Players in 2016
Figure Next Generation Cancer Diagnostics Market Size Share by Players in 2017
Table Cepheid Basic Information List
Table Next Generation Cancer Diagnostics Business Revenue (Million USD) of Cepheid (2012-2017)
Figure Cepheid Next Generation Cancer Diagnostics Business Revenue Market Share in 2016
Table Koninklijke Philips N.V Basic Information List
Table Next Generation Cancer Diagnostics Business Revenue (Million USD) of Koninklijke Philips N.V (2012-2017)
Figure Koninklijke Philips N.V Next Generation Cancer Diagnostics Business Revenue Market Share in 2016
Table F. Hoffmann-La Roche Ltd Basic Information List
Table Next Generation Cancer Diagnostics Business Revenue (Million USD) of F. Hoffmann-La Roche Ltd (2012-2017)
Figure F. Hoffmann-La Roche Ltd Next Generation Cancer Diagnostics Business Revenue Market Share in 2016
Table Qiagen Basic Information List
Table Next Generation Cancer Diagnostics Business Revenue (Million USD) of Qiagen (2012-2017)
Figure Qiagen Next Generation Cancer Diagnostics Business Revenue Market Share in 2016
Table Novartis AG Basic Information List
Table Next Generation Cancer Diagnostics Business Revenue (Million USD) of Novartis AG (2012-2017)
Figure Novartis AG Next Generation Cancer Diagnostics Business Revenue Market Share in 2016
Table Abbott Basic Information List
Table Next Generation Cancer Diagnostics Business Revenue (Million USD) of Abbott (2012-2017)
Figure Abbott Next Generation Cancer Diagnostics Business Revenue Market Share in 2016
Table Thermo Fisher Scientific Basic Information List
Table Next Generation Cancer Diagnostics Business Revenue (Million USD) of Thermo Fisher Scientific (2012-2017)
Figure Thermo Fisher Scientific Next Generation Cancer Diagnostics Business Revenue Market Share in 2016
Table Opko Health Basic Information List
Table Next Generation Cancer Diagnostics Business Revenue (Million USD) of Opko Health (2012-2017)
Figure Opko Health Next Generation Cancer Diagnostics Business Revenue Market Share in 2016
Table Myriad Genetics Basic Information List
Table Next Generation Cancer Diagnostics Business Revenue (Million USD) of Myriad Genetics (2012-2017)
Figure Myriad Genetics Next Generation Cancer Diagnostics Business Revenue Market Share in 2016
Table Agilent Technologies Basic Information List
Table Next Generation Cancer Diagnostics Business Revenue (Million USD) of Agilent Technologies (2012-2017)
Figure Agilent Technologies Next Generation Cancer Diagnostics Business Revenue Market Share in 2016
Table GE Healthcare Basic Information List
Table Next Generation Cancer Diagnostics Business Revenue (Million USD) of GE Healthcare (2012-2017)
Figure GE Healthcare Next Generation Cancer Diagnostics Business Revenue Market Share in 2016
Table PerkinElmer Basic Information List
Table Next Generation Cancer Diagnostics Business Revenue (Million USD) of PerkinElmer (2012-2017)
Figure PerkinElmer Next Generation Cancer Diagnostics Business Revenue Market Share in 2016
Table Genomic Health Basic Information List
Table Next Generation Cancer Diagnostics Business Revenue (Million USD) of Genomic Health (2012-2017)
Figure Genomic Health Next Generation Cancer Diagnostics Business Revenue Market Share in 2016
Table Illumina Basic Information List
Table Next Generation Cancer Diagnostics Business Revenue (Million USD) of Illumina (2012-2017)
Figure Illumina Next Generation Cancer Diagnostics Business Revenue Market Share in 2016
Table Hologic Basic Information List
Table Next Generation Cancer Diagnostics Business Revenue (Million USD) of Hologic (2012-2017)
Figure Hologic Next Generation Cancer Diagnostics Business Revenue Market Share in 2016
Table Almac Group Basic Information List
Table Next Generation Cancer Diagnostics Business Revenue (Million USD) of Almac Group (2012-2017)
Figure Almac Group Next Generation Cancer Diagnostics Business Revenue Market Share in 2016
Table Janssen Global Services Basic Information List
Table Next Generation Cancer Diagnostics Business Revenue (Million USD) of Janssen Global Services (2012-2017)
Figure Janssen Global Services Next Generation Cancer Diagnostics Business Revenue Market Share in 2016
Table Sysmex Corporation Basic Information List
Table Next Generation Cancer Diagnostics Business Revenue (Million USD) of Sysmex Corporation (2012-2017)
Figure Sysmex Corporation Next Generation Cancer Diagnostics Business Revenue Market Share in 2016
Table Global Next Generation Cancer Diagnostics Market Size (Million USD) by Type (2012-2017)
Figure Global Next Generation Cancer Diagnostics Market Size Share by Type in 2012
Figure Global Next Generation Cancer Diagnostics Market Size Share by Type in 2013
Figure Global Next Generation Cancer Diagnostics Market Size Share by Type in 2014
Figure Global Next Generation Cancer Diagnostics Market Size Share by Type in 2015
Figure Global Next Generation Cancer Diagnostics Market Size Share by Type in 2016
Figure Global Next Generation Cancer Diagnostics Market Size Share by Type in 2017
Table Global Next Generation Cancer Diagnostics Market Size (Million USD) by Application (2012-2017)
Figure Global Next Generation Cancer Diagnostics Market Size (Million USD) by Application in 2012
Figure Global Next Generation Cancer Diagnostics Market Size (Million USD) by Application in 2013
Figure Global Next Generation Cancer Diagnostics Market Size (Million USD) by Application in 2014
Figure Global Next Generation Cancer Diagnostics Market Size (Million USD) by Application in 2015
Figure Global Next Generation Cancer Diagnostics Market Size (Million USD) by Application in 2016
Figure Global Next Generation Cancer Diagnostics Market Size (Million USD) by Application in 2017
Table Top Consumer/End Users of Next Generation Cancer Diagnostics
Figure United States Next Generation Cancer Diagnostics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table United States Next Generation Cancer Diagnostics Market Size (Million USD) by Players (2012-2017)
Figure United States Next Generation Cancer Diagnostics Market Size Share by Players in 2016
Figure United States Next Generation Cancer Diagnostics Market Size Share by Players in 2017
Figure EU Next Generation Cancer Diagnostics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table EU Next Generation Cancer Diagnostics Market Size (Million USD) by Players (2012-2017)
Figure EU Next Generation Cancer Diagnostics Market Size Share by Players in 2016
Figure EU Next Generation Cancer Diagnostics Market Size Share by Players in 2017
Figure Japan Next Generation Cancer Diagnostics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Japan Next Generation Cancer Diagnostics Market Size (Million USD) by Players (2012-2017)
Figure Japan Next Generation Cancer Diagnostics Market Size Share by Players in 2016
Figure Japan Next Generation Cancer Diagnostics Market Size Share by Players in 2017
Figure China Next Generation Cancer Diagnostics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table China Next Generation Cancer Diagnostics Market Size (Million USD) by Players (2012-2017)
Figure China Next Generation Cancer Diagnostics Market Size Share by Players in 2016
Figure China Next Generation Cancer Diagnostics Market Size Share by Players in 2017
Figure India Next Generation Cancer Diagnostics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table India Next Generation Cancer Diagnostics Market Size (Million USD) by Players (2012-2017)
Figure India Next Generation Cancer Diagnostics Market Size Share by Players in 2016
Figure India Next Generation Cancer Diagnostics Market Size Share by Players in 2017
Figure Southeast Asia Next Generation Cancer Diagnostics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Southeast Asia Next Generation Cancer Diagnostics Market Size (Million USD) by Players (2012-2017)
Figure Southeast Asia Next Generation Cancer Diagnostics Market Size Share by Players in 2016
Figure Southeast Asia Next Generation Cancer Diagnostics Market Size Share by Players in 2017
Figure Global Next Generation Cancer Diagnostics Market Size (Million USD) by Regions (2017-2022)
Table Global Next Generation Cancer Diagnostics Market Size (Million USD) by Regions (2017-2022)
Figure Global Next Generation Cancer Diagnostics Market Size Share by Regions in 2017
Figure Global Next Generation Cancer Diagnostics Market Size Share by Regions in 2022
Figure United States Next Generation Cancer Diagnostics Revenue (Million USD) and Growth Rate (2017-2022)
Figure EU Next Generation Cancer Diagnostics Revenue (Million USD) and Growth Rate (2017-2022)
Figure Japan Next Generation Cancer Diagnostics Revenue (Million USD) and Growth Rate (2017-2022)
Figure China Next Generation Cancer Diagnostics Revenue (Million USD) and Growth Rate (2017-2022)
Figure India Next Generation Cancer Diagnostics Revenue (Million USD) and Growth Rate (2017-2022)
Figure Southeast Asia Next Generation Cancer Diagnostics Revenue (Million USD) and Growth Rate (2017-2022)
Table Global Next Generation Cancer Diagnostics Market Size (Million USD) by Type (2017-2022)
Figure Global Next Generation Cancer Diagnostics Market Size Share by Type in 2017
Figure Global Next Generation Cancer Diagnostics Market Size Share by Type in 2022
Table Global Next Generation Cancer Diagnostics Market Size (Million USD) by Application (2017-2022)
Figure Global Next Generation Cancer Diagnostics Market Size (Million USD) by Application in 2017
Figure Global Next Generation Cancer Diagnostics Market Size (Million USD) by Application in 2022
